drugset
drugset / Trial / NCT02068105

A Study of ALKS 5461 in Healthy Volunteers

NCT02068105 ↗

Phase 1 Completed 104 enrolled Alkermes, Inc.
RandomizedCrossoverQuadruple-blindTreatment

Summary

This is a study to test the safety of ALKS 5461 in healthy adults.

Timeline

Start
2014-01
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject ALKS 5461 Unknown — Other

Indications

No indication recorded.